Additional file 3 of An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile

  • Maria Laura De Angelis (Creator)
  • Federica Francescangeli (Creator)
  • Chiara Nicolazzo (Creator)
  • Michele Signore (Creator)
  • Alessandro Giuliani (Creator)
  • Lidia Colace (Creator)
  • Alessandra Boe (Creator)
  • Valentina Magri (Creator)
  • Marta Baiocchi (Creator)
  • Antonio Ciardi (Creator)
  • Francesco Scarola (Creator)
  • Massimo Spada (Creator)
  • Filippo La Torre (Creator)
  • Paola Gazzaniga (Creator)
  • Mauro Biffoni (Creator)
  • Ruggero De Maria Marchiano (Creator)
  • Ann Zeuner (Creator)

Dataset

Description

Additional file 3: Table S2. List of compounds used in the screening: drug name, targets Selleckchem catalogue number and doses are reported. Anti-cancer compounds (sheet 1) have been used at a 200 nM concentration, whereas low toxicity compounds (sheet 2) have been used at the indicated doses in order to identify the LD50 value reported in Fig. 5E.
Dati resi disponibili2022
Editorefigshare

Cita questo